Skip to main content
MB

metaBIX Biotech

metaBIX develops advanced computational tools for accelerating drug discovery pipelines. The platform integrates machine learning models with high-throughput screening data to predict compound efficacy and toxicity profiles. This capability allows pharmaceutical researchers to rapidly identify viable therapeutic candidates with optimized physicochemical properties.

Montevideo, UruguayFounded 202262K+ followers
Updated 4 months ago

Funding

$185K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Current methods for detecting airborne pathogens often lack the speed and sensitivity needed to provide early warnings of potential disease outbreaks affecting plants, animals, and humans. Traditional monitoring techniques may also be limited in scope, failing to capture the full environmental pressure of infection. This can result in delayed implementation of preventive measures, increasing the risk of widespread disease and economic losses.

Solution

metaBIX Biotech offers an integrated platform that combines hardware, biotechnology, and artificial intelligence to proactively monitor airborne pathogens and assess the environmental pressure of infection. The system uses specialized air sampling devices to capture and analyze airborne microorganisms, identifying both known and emerging diseases. Proprietary AI algorithms then process the data to provide early warnings of potential outbreaks, giving clients at least two weeks' notice to implement preventive measures. This enables timely intervention, minimizing the impact of diseases on ecosystems and communities.

Target Audience

The primary target audience includes organizations and individuals concerned with the health and safety of plants, animals, and humans, such as agricultural businesses, zoos, environmental agencies, and public health organizations.

Features

  • Real-time monitoring of airborne pathogens using advanced air sampling devices
  • Identification of both known and emerging diseases through biotechnology analysis
  • AI-powered predictive analytics for early warning of potential outbreaks
  • Specialized software platform for data visualization and reporting
  • Integration of hardware, biotechnology, and AI for comprehensive environmental monitoring
This profile is AI-generated and may contain inaccuracies.